ETF Components for PBE - PowerShares Dynamic Biotech & Genome
Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.
Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.
Holdings
| Symbol | Grade | Price % Change | Allocation | |
|---|---|---|---|---|
| UTHR | C | 0.67 | 5.74 | |
| ILMN | C | -0.11 | 5.64 | |
| ALNY | D | -0.47 | 4.78 | |
| AMGN | D | -0.96 | 4.70 | |
| BIIB | F | -0.29 | 4.21 | |
| NBIX | C | -0.17 | 4.18 | |
| XNCR | B | 0.44 | 3.88 | |
| EXEL | B | 0.04 | 3.86 | |
| TGTX | B | 5.46 | 3.78 | |
| BMRN | F | -1.35 | 3.76 | |
| MNKD | B | -1.01 | 3.70 | |
| NTRA | A | -1.04 | 3.56 | |
| REGN | F | -0.48 | 3.38 | |
| INCY | C | -0.95 | 3.35 | |
| VCYT | B | -0.40 | 3.28 | |
| ACAD | C | -3.01 | 3.06 | |
| CPRX | C | -0.71 | 3.00 | |
| BPMC | C | -0.90 | 2.91 | |
| TECH | F | 0.49 | 2.89 | |
| VCEL | A | 0.59 | 2.79 | |
| OPK | B | -0.32 | 2.78 | |
| RGEN | D | -1.13 | 2.76 | |
| PTGX | D | 4.06 | 2.75 | |
| QGEN | D | 0.29 | 2.59 | |
| BCRX | D | -1.44 | 2.56 | |
| HALO | F | 0.15 | 2.42 | |
| COLL | F | 1.43 | 2.27 | |
| CDNA | D | -0.98 | 1.92 | |
| NVAX | F | 0.12 | 1.83 | |
| MYGN | F | -0.39 | 1.61 |
Represented by ETF Holdings
Recent News for PowerShares Dynamic Biotech & Genome & its Holdings
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Invesco Powershares Genetic Engineering Inter 10 Index Genome
Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Invesco Powershares Genetic Engineering Inter 10 Index Genome
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles
